NASDAQ: APLS - Apellis Pharmaceuticals, Inc.

六个月盈利: -23.53%
股息率: 0.00%
部门: Healthcare

促销时间表 Apellis Pharmaceuticals, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Apellis Pharmaceuticals, Inc., биофармацевтическая компания, работающая на клинической стадии, специализируется на разработке терапевтических соединений посредством ингибирования системы комплемента при аутоиммунных и воспалительных заболеваниях.

更多详情
Ведущим кандидатом на продукт является пегцетакоплан, который проходит III фазу клинических испытаний для лечения географической атрофии при возрастной дегенерации желтого пятна и пароксизмальной ночной гемоглобинурии; и в фазе II клинических испытаний для лечения болезни холодовых агглютининов, гломерулопатии C3, нефропатии IgA, первичной мембранозной нефропатии и волчаночного нефрита. Компания также разрабатывает APL-9, который находится в фазе I рандомизированных, двойных слепых и плацебо-контролируемых клинических испытаний однократной возрастающей дозы для предотвращения активации иммунной системы, совпадающей с аденоассоциированным вирусом для внутривенного введения. Apellis Pharmaceuticals, Inc. имеет стратегическое сотрудничество со шведской Orphan Biovitrum AB (publ) для развития пегцетакоплана, препарата C3 для лечения множества редких заболеваний, включая пароксизмальную ночную гемоглобинурию. Компания была основана в 2009 году и базируется в Уолтеме, штат Массачусетс.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2017-11-09
ISIN US03753U1060
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.apellis.com
Цена ао 27.44
每日价格变化: -2.47% (30.76)
每周价格变化: +0.2171% (29.935)
每月价格变化: -9.96% (33.32)
3个月内价格变化: +12.44% (26.68)
六个月内的价格变化: -23.53% (39.23)
每年价格变化: -53.15% (64.04)
3年内价格变化: -30.3% (43.04)
5年内价格变化: -25.93% (40.5)
年初以来价格变化: -9.96% (33.32)
所有参数

低估

姓名 意义 年级
P/S 17.27 1
P/BV 35.22 1
P/E 0 0
EV/EBITDA -12.82 0
全部的: 3.25

效率

姓名 意义 年级
ROA, % -67.02 0
ROE, % -271.76 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.193 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 58.26 7
盈利能力 Ebitda, % 75.11 8
盈利能力 EPS, % -13.68 0
全部的: 6.6
更多详情

交易日期 披露日期 内幕 类型 价格 体积 数量 分享最多, % 之后分享, % 文档
29.01.2025 29.01.2025 Deschatelets Pascal
Officer		 购买 29.52 24 384 826 0 0 关联
29.01.2025 29.01.2025 Eisele Jeffrey
Officer		 购买 29.52 8 207 278 0 0 关联
29.01.2025 29.01.2025 Francois Cedric
Officer		 购买 29.52 83 364 2824 0 0 关联
29.01.2025 29.01.2025 Watson David O.
Officer		 购买 29.52 20 516 695 0 0 关联
29.01.2025 29.01.2025 DeLong Mark Jeffrey
Officer		 购买 29.52 10 775 365 0 0 关联
29.01.2025 29.01.2025 Nicholson Nur
Officer		 购买 29.52 24 354 825 0 0 关联
29.01.2025 29.01.2025 Lewis Karen
Officer		 购买 29.52 10 745 364 0 0 关联
29.01.2025 29.01.2025 Sullivan Timothy Eugene
Officer		 购买 29.52 16 118 546 0 0 关联
29.01.2025 29.01.2025 Townsend Adam J.
Officer		 购买 29.52 20 516 695 0 0 关联
22.01.2025 22.01.2025 Nicholson Nur
Officer		 购买 30.43 120 138 3948 0 0 关联
22.01.2025 22.01.2025 Chopas James George
Officer		 购买 30.43 33 351 1096 0 0 关联
22.01.2025 22.01.2025 Eisele Jeffrey
Officer		 购买 30.43 39 285 1291 0 0 关联
22.01.2025 22.01.2025 DeLong Mark Jeffrey
Officer		 购买 30.43 42 480 1396 0 0 关联
22.01.2025 22.01.2025 Townsend Adam J.
Officer		 购买 30.43 101 119 3323 0 0 关联
22.01.2025 22.01.2025 Deschatelets Pascal
Officer		 购买 30.43 120 138 3948 0 0 关联
22.01.2025 22.01.2025 Sullivan Timothy Eugene
Officer		 购买 30.43 93 968 3088 0 0 关联
22.01.2025 22.01.2025 Lewis Karen
Officer		 购买 30.43 53 283 1751 0 0 关联
22.01.2025 22.01.2025 Watson David O.
Officer		 购买 30.43 101 119 3323 0 0 关联
22.01.2025 22.01.2025 Francois Cedric
Officer		 购买 30.43 412 357 13551 0 0.01 关联
17.01.2025 21.01.2025 Baumal Caroline
Chief Medical Officer		 销售 29.96 55 516 1853 0 0 关联
17.01.2025 21.01.2025 Chopas James George
VP/Chief Accounting Officer		 销售 29.96 21 421 715 0 0 关联
17.01.2025 21.01.2025 DeLong Mark Jeffrey
Chief Business & Strat Officer		 销售 29.96 37 001 1235 0 0 关联
13.01.2025 13.01.2025 Nicholson Nur
Officer		 购买 28.7 76 945 2681 0 0 关联
13.01.2025 13.01.2025 Eisele Jeffrey
Officer		 购买 28.7 7 577 264 0 0 关联
13.01.2025 13.01.2025 Townsend Adam J.
Officer		 购买 28.7 78 466 2734 0 0 关联
13.01.2025 13.01.2025 Sullivan Timothy Eugene
Officer		 购买 28.7 63 398 2209 0 0 关联
13.01.2025 13.01.2025 Lewis Karen
Officer		 购买 28.7 46 695 1627 0 0 关联
06.01.2025 08.01.2025 Baumal Caroline
Chief Medical Officer		 销售 33.81 95 209 2816 0 0 关联
06.01.2025 06.01.2025 Baumal Caroline
Officer		 购买 33.81 95 209 2816 0 0 关联
23.12.2024 27.12.2024 Eisele Jeffrey
Chief Development Officer		 销售 33.09 2 085 63 0 0 关联
23.12.2024 23.12.2024 Eisele Jeffrey
Officer		 购买 33.09 2 085 63 0 0 关联
12.08.2024 13.08.2024 DeLong Mark Jeffrey
Chief Business & Strat Officer		 购买 13.85 72 034 5201 0 0.01 关联
28.06.2024 01.07.2024 Dunlop A. Sinclair
Director		 购买 13.19 11 871 900 0 0 关联
20.05.2024 21.05.2024 Deschatelets Pascal
Chief Scientific Officer		 购买 3.76 92 120 24500 0 0.03 关联
12.04.2024 15.04.2024 Dunlop A. Sinclair
Director		 购买 13.19 19 785 1500 0 0 关联
08.04.2024 09.04.2024 Deschatelets Pascal
Chief Scientific Officer		 销售 54.17 3 743 530 69107 0 -0.07 关联
08.04.2024 09.04.2024 Deschatelets Pascal
Chief Scientific Officer		 购买 3.76 259 842 69107 0 0.07 关联
18.03.2024 19.03.2024 DeLong Mark Jeffrey
Chief Business & Strat Officer		 销售 56.9 564 050 9913 0 -0.01 关联
08.03.2024 11.03.2024 Deschatelets Pascal
Chief Scientific Officer		 销售 62.19 4 297 760 69107 0 -0.07 关联
08.03.2024 11.03.2024 Deschatelets Pascal
Chief Scientific Officer		 购买 3.67 253 623 69107 0 0.07 关联
22.01.2024 23.01.2024 Eisele Jeffrey
Chief Development Officer		 销售 65 104 455 1607 0 0 关联
22.01.2024 23.01.2024 Lewis Karen
Chief People Officer		 销售 65 112 970 1738 0 0 关联
22.01.2024 23.01.2024 Nicholson Nur
Chief Technical Officer		 销售 65 168 545 2593 0 0 关联
22.01.2024 23.01.2024 Sullivan Timothy Eugene
Chief Financial Officer		 销售 65 230 815 3551 0 0 关联
22.01.2024 23.01.2024 Chopas James George
VP/Chief Accounting Officer		 销售 65 68 965 1061 0 0 关联
22.01.2024 23.01.2024 DeLong Mark Jeffrey
Chief Business & Strat Officer		 销售 65 89 960 1384 0 0 关联
22.01.2024 23.01.2024 Deschatelets Pascal
Chief Scientific Officer		 销售 65 254 345 3913 0 0 关联
06.09.2023 07.09.2023 SCHEIBLER LUKAS
Chief Research Officer		 销售 43.01 75 526 1756 0 0 关联
10.04.2023 11.04.2023 Deschatelets Pascal
Chief Scientific Officer		 销售 78.21 938 520 12000 0 -0.01 关联
10.04.2023 11.04.2023 Deschatelets Pascal
Chief Scientific Officer		 购买 2.67 49 395 18500 0 0.02 关联
05.01.2023 09.01.2023 Grossi Federico
Chief Medical Officer		 销售 48.79 121 975 2500 0 0 关联
15.07.2022 18.07.2022 Machiels Alec
Director		 销售 46.33 57 913 1250 0 0 关联
15.07.2022 18.07.2022 Machiels Alec
Director		 购买 2.67 3 338 1250 0 0 关联
14.04.2022 18.04.2022 Machiels Alec
Director		 销售 50.9 63 625 1250 0 0 关联
14.04.2022 18.04.2022 Machiels Alec
Director		 购买 2.67 3 338 1250 0 0 关联
01.03.2022 02.03.2022 Grossi Federico
CHIEF MEDICAL OFFICER		 销售 43.53 16 324 375 0 0 关联

机构 体积 分享, %
Wellington Management Group, LLP 16445290 13.64
EcoR1 Capital, LLC 11173068 9.27
Avoro Capital Advisors LLC 11111111 9.21
Vanguard Group Inc 9555678 7.92
T. Rowe Price Investment Management, Inc. 6303584 5.23
Blackrock Inc. 5381253 4.46
Jennison Associates LLC 3275922 2.72
Morgan Stanley 3097141 2.57
State Street Corporation 2915422 2.42
Octagon Capital Advisors LP 2806980 2.33

ETF 分享, % 本年盈利能力, % 股息, %
Virtus LifeSci Biotech Products ETF 1.25033 36.79 0.13953
Direxion Daily S&P Biotech Bull 3x Shares 0.72649 4067.92 0.25924
Invesco Nasdaq Biotechnology ETF 0.42966 28.58 0.8565
Future Tech ETF 0.3828 426.34 0.8416
Principal Healthcare Innovators ETF 0.3828 618.5 0.8416
ProShares UltraShort Nasdaq Biotechnology 0.31 -40.36 1.76
ProShares Ultra Nasdaq Biotechnology 0.28736 51.7 0.85651
SoFi Next 500 ETF 0.21461 29.56 1.43041
BNY Mellon US Small Cap Core Equity ETF 0.17885 30.07 1.75333
First Trust Nasdaq BuyWrite Income ETF 0.13966 7.27 0.92977
iShares Russell Mid-Cap Growth ETF 0.12215 29.59 0.69551
iShares Morningstar Small-Cap Growth ETF 0.11349 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.11349 587.89 0.72598
Schwab U.S. Small-Cap ETF 0.10162 17.47 1.51433
Schwab US Mid-Cap ETF 0.08896 17.28 1.59098
JPMorgan BetaBuilders U.S. Mid Cap Equity ETF 0.07892 21.79 1.42082
Invesco Russell 1000 Equal Weight ETF 0.07215 16.58 2.1901
iShares Morningstar Small-Cap ETF 0.05723 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.05723 30.1 1.60498
iShares Russell 2500 ETF 0.05412 18.06 1.58987
Fidelity MSCI Health Care Index ETF 0.04297 3 1.46057
iShares ESG Aware MSCI USA Small-Cap ETF 0.03992 18.09 1.49366
iShares Russell Midcap ETF 0.02911 20.77 1.71565
Humankind US Stock ETF 0.02307 18.81 1.99919
Vanguard Russell 1000 Growth ETF 0.02 31.62 0.68737
iShares Russell 1000 Growth ETF 0.01232 31.85 0.68889
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
Vanguard Russell 1000 ETF 0.01 25.16 1.43539
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Columbia Research Enhanced Core ETF 0.00789 33.58 1.60295
Schwab 1000 Index ETF 0.00725 25.15 1.42441
Schwab U.S. Broad Market ETF 0.00695 24.86 1.43354
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00691 21.94 1.69572
iShares Dow Jones U.S. ETF 0.00649 25.05 1.41797
Goldman Sachs MarketBeta U.S. 1000 Equity ETF 0.00624 33 1.42661
iShares Russell 3000 ETF 0.00582 24.83 1.43482
SPDR Portfolio MSCI Global Stock Market ETF 0.00126 17.99 2.19607
Avantis U.S. Equity ETF 0.00096 23.04 1.59151
Dimensional U.S. Core Equity 2 ETF 0.00045 30.76 1.47098
Convergence Long/Short Equity ETF -0.27227 32.85 1.56428



导师 职称 支付 出生年份
Mr. Alec Machiels J.D., MBA Co-Founder & Director 72.5k 1973 (52 年)
Mr. Timothy E. Sullivan CFO & Treasurer 716.41k 1971 (54 年)
Mr. Adam J. Townsend Chief Operating Officer 701.61k 1978 (47 年)
Mr. James G. Chopas CPA VP, Corporate Controller & Chief Accounting Officer N/A 1967 (58 年)
Ms. Meredith Kaya Senior Vice President, Investor Relations & Strategic Finance N/A
Dr. Cedric Francois M.D., Ph.D. Co-Founder, President, CEO & Director 1.2M 1972 (53 年)
Dr. Pascal Deschatelets Ph.D. Co-Founder & Chief Scientific Officer 688.05k 1970 (55 年)
Mr. David O. Watson Esq., J.D. General Counsel 675.35k 1973 (52 年)
Ms. Karen Lewis Chief People Officer N/A 1973 (52 年)
Dr. Caroline R. Baumal M.D. Chief Medical Officer 1968 (57 年)

地址: United States, Waltham, MA , 100 Fifth Avenue - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.apellis.com